Eli Lilly and Company (LLY) vs Meta Platforms, Inc. (META)
See how Eli Lilly and Company and Meta Platforms, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$1,179.11
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
Meta Platforms, Inc. is the world’s largest social media company, reaching nearly 4 billion monthly active users globally. Its core business, known as the Family of Apps, includes Facebook, Instagram, Messenger, and WhatsApp. Users rely on these platforms for a wide range of activities, from staying connected with friends and following public figures to operating digital businesses at no cost. Meta monetizes its ecosystem by using customer data generated across its apps to sell advertising to digital marketers. Although the company has invested significantly in Reality Labs, that segment still represents only a small portion of Meta’s total revenue.